THANOSWITCH
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Dec 2023)
What this means for you
This application is over — abandoned 25 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90692260
- Mark type
- Stylized text
- Filed
- 05 May 2021
- Published for opposition
- 28 Mar 2023
- Abandoned
- 25 Dec 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules for medical use, for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others
Owner
- SONATA THERAPEUTICS, INC., CAMBRIDGE, MA, US
- SONATA THERAPEUTICS, INC., CAMBRIDGE, MA, US
- Inzen Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 26 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 23 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Mar 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Mar 2023 — PUBLISHED FOR OPPOSITION
- 08 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Feb 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Feb 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Feb 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Jan 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Aug 2022 — NON-FINAL ACTION E-MAILED
- 08 Aug 2022 — NON-FINAL ACTION WRITTEN
- 08 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED